The C3H/HeJ mouse strain bears an autosomal gene defect, Lpsd, which results in a greatly diminished capacity to respond to endotoxin, the ubiquitous lipolysaccharide derived from the cell walls of gram-negative bacteria. These mice also exhibit greater susceptibility to a variety of viral and bacterial infections than syngeneic, fully lipopolysaccharide-responsive (Lps') mouse strains and possess macrophages with defects in differentiation which are reversed by treatment with exogenous interferon (IFN). To test directly the hypothesis that C3H/HeJ macrophages are deficient in endogenous IFN levels, macrophages from C3H/HeJ (Lpsd) and C3H/OuJ (Lps') mice were compared for sensitivity to vesicular stomatitis virus. At a multiplicity of infection of 0.1, C3H/OuJ macrophages were completely refractory to infection, whereas C3H/HeJ macrophages were permissive for replication, and infection resulted in 100% cytopathic effect. These findings were confirmed with a second inbred Lps' and Lpsd strain pair. Levels of 2',5'-oligoadenylate synthetase were significantly higher in Lps' cells. C3H/HeJ macrophages, derived from bone marrow precursors under the influence of macrophage colony-stimulating factor, shown previously to induce IFN in macrophages, were as refractory as C3H/OuJ macrophages. Exposure of nonpermissive macrophages to anti-IFN-a/I antibody prior to infection rendered cells permissive. Our findings suggest that endotoxin provides a primary stimulus for the maintenance of normal macrophage differentiation and innate resistance via the induction of endogenous IFN by macrophages.
The C3H/HeJ mouse strain bears a single autosomal mutation on chromosome 4, Lpsd (40) , which renders it highly refractory to the diverse biologic effects of gramnegative endotoxins in vitro (reviewed in references 24, 25, and 37). The failure of this mouse strain to respond to the toxic manifestations of lipopolysaccharide (LPS) appears to stem from a failure of their macrophages to respond to LPS to produce inflammatory products (i.e., interleukin 1 or endogenous pyrogen, tumor necrosis factor, glucocorticoid antagonizing factor, prostaglandins [16, 20, 37] ), which under normal circumstances mediate many of the manifestations associated with endotoxemia. To date, neither the product of the normal allele, Lps', nor the product of the Lpsd locus has been isolated or characterized. In addition to their profound hyporesponsiveness to LPS, C3H/HeJ mice differ significantly from their fully endotoxin-responsive counterparts in that they are highly susceptible to a wide variety of viral and bacterial pathogens (reviewed in reference 26) , and in several of these studies, susceptibility to infection was genetically mapped to the Lpsd allele. Moreover, not only do C3H/HeJ macrophages fail to respond to LPS in vitro, but macrophages derived from this strain exhibit in vitro a significantly lowered differentiation state, as assessed by a decreased capacity to bind and phagocytose immunoglobulin G (IgG)-coated sheep erthyrocytes via their Fc receptors (35) . The reduced Fc receptor capacity of these macrophages could be greatly augmented by treating cultures with alpha, beta, or gamma interferons (IFN) (5, 36) . This observation led us to hypothesize that C3H/HeJ macrophages produce significantly lower endogenous IFN levels than macrophages derived from fully LPS-responsive strains. Thus, a lowered state of macrophage differentiation (secondary to a reduced level of endogenous IFN) might underlie the observed increase in susceptibility to infection. Increased susceptibility to viral infection has been induced in mice injected with high-titered antibody to IFN-a/I (2, 8-9, 10, 29) , suggesting that endogenous levels of IFN may contribute to innate resistance to certain infections. However, it has been clearly pointed out by Gresser (8) that, to date, a naturally occurring genetic model has not been described.
In this report we have demonstrated that peritoneal exudate macrophages from fully LPS-responsive (Lps') C3H/OuJ mice are refractory to infection with vesicular stomatitis virus (VSV), whereas LPS-hyporesponsive C3H/HeJ macrophages support the replication of VSV. Macrophage sensitivity to VSV was confirmed in a second mouse strain, C57BL/1OScN, which also bears the Lpsd allele (31, 39) . Basal levels of 2',5'-oligoadenylate (2,5-A) synthetase were significantly higher in the nonpermissive C3H/OuJ macrophages. If the C3H/HeJ macrophages were derived from bone marrow progenitors under the influence of macrophage colony-stimulating factor (CSF-1), shown recently by Moore (38) . Briefly, after 7 days in culture with CSF-1 (-1,000 U/ml), mature, adherent, bone marrow-derived macrophages were removed enzymatically from the flasks with the neutral protease (27) . The concentration of protein was measured by the method of Lowry et al. (15) . A modification of the method of Stark et al. (27) (31, 39) . Macrophages derived from the fully endotoxin-sensitive (Lps') counterpart of this strain, the C57BL/1OJ strain, were refractory to VSV infection (Fig. 1C) .
The effect of time in culture prior to infection was also examined, since our previous studies had indicated that C3H/HeJ macrophages continue to lose Fc receptor capacity with time in culture (35) . The rophages to VSV increased with time in culture, whereas the inability of C3H/OuJ macrophages to replicate VSV was sustained over the 2-day culture period (Fig. 2) from bone marrow stem cells to mature macrophages by fibroblast-derived CSF-1. Therefore, we compared the permissive C3H/HeJ peritoneal exudate macrophages with bone marrow-derived macrophage cultures from the same strain. When C3H/HeJ macrophages were derived from the bone marrow under the influence of CSF-1, they were as refractory to VSV infection as the fully endotoxin-responsive C3H/OuJ peritoneal exudate macrophages ( Fig. 3 ; cf. Fig. 1 and 2), regardless of how long they were cultured in the absence of CSF-1 prior to infection. TG-treated C3H/HeJ macrophages treated with the enzyme Dispase II under the same conditions as the bone marrow-derived macrophages (prior to their culture in 96-well plates) were as sensitive to VSV as the control (mock-infected, Earle balanced salt solution-treated) macrophages, whether infected in Do or D2 (data not shown). This experiment also reillustrates the finding (Fig. 2) (Fig. 4) . The concentration of antibody chosen for these experiments was based on the lowest concentration, determined in our earlier study, required to reduce Fc receptor capacity in Lps' macrophages to levels which approached the deficit response of C3H/HeJ macrophages (30 (31) and is a noncomplemnenting genetic lesion (i.e., F1 mice exhibit no increase in LPS sensitivity [39] ). Thus, demonstration of VSV permissiveness in macrophages derived from these two strains greatly strengthens the evidence for the role of the Lpsn allele in macrophage resistance to VSV infection.
It is important to note that the C3H/HeJ defect (i.e., the Lpsd allele) results in hyporesponsiveness to LPS only, not to. other bacterial products or IFN inducers (reviewed in reference 25). For instance, we have found that injection of poly(I:C) (100 jg) into C3H/HeJ mice results in the production of very high serum IFN levels (51,200 UI/ml) within 2 h. Thus, our findings provide strong support for the hypothesis that LPS is a major "environmental" signal responsible for natural resistance to viral infection. Moreover, the finding in this report that direct treatment of the LPS-responsive macrophages with anti-IFN-od/1 antibody significantly reversed their nonpermissiveness suggests that the macrophage is, in fact, the source of the endogenous IFN in this situation. The failure of anti-IFN-oa/1 to reverse completely the VSV resistance of C3H/OuJ or CSF-1-derived C3H/HeJ macrophages (Fig. 4) is most likely related to antibody concentration and degradation of antibody by macrophages (as opposed to other cell types). The anti-IFN-a/p concentration used in this study was chosen because in previous studies (30), a 1:250 to 1:500 dilution of this same antibody preparation consistently led to a reversal of Fc receptor capacity in Lps' macrophages which approached the deficient level exhibited by C3H/HeJ macrophages. In addition, macrophages required significantly more anti-IFN-y antibody than L929 fibroblasts to neutralize exogenous IFN--yinduced antiviral activity (32) , suggesting that macrophages may degrade antibody more rapidly than other cell types.
The partial reversal of VSV resistance (Fig. 4) (12) and that LPS fails to induce IFN in C3H/HeJ mice in vivo (17) or in C3H/HeJ macrophage cultures (R. N. Moore, personal communication). In a previous study, attempts to measure antiviral activity directly in supernatants of Lps' and Lpsd peritoneal exudate macrophage cultures were unsuccessful due to very low levels released into the culture supernatants (30) . However, Moore et al. (21) recently demonstrated low but measurable levels of antiviral activity in CSF-stimulated bone marrow cultures. The finding that C3H/HeJ macrophages derived from bone niarrow progenitors under the influence of CSF-1 were phenotypically identical to C3H/OuJ (Lps') peritoneal exudate macrophages with respect to VSV sensitivity suggests that the failure of C3H/HeJ peritoneal macrophages to produce endogenous IFN may be secondary to a failure to produce normal levels of CSF. Since it is known that injection of LPS also fails to induce CSF in C3H/HeJ mice (1, 19) , the failure to respond to naturally occurring levels of LPS to produce CSF may underlie the deficit in endogenous IFN production.
The findings presented in this report also support the hypothesis that, in addition to increasing resistance to virus infection, endogenous IFN simultaneously provides an autostimulatory differentiative signal to the macrophage.
The defective Fc receptor capacity exhibited by C3H/HeJ macrophages (as well as VSV sensitivity [32] ) can be overcome to exogenous treatment of the macrophages with IFN (5, 36) , whereas the normal Fc receptor capacity exhibited by C3H/HeN (Lps') macrophages was shown previously to be depressed by treatment with anti-IFN-oa/ antibody (30) .
In addition, the findings presented herein are consistent with recent observations by Moore et al. (22) and Warren and Vogel (38) , which demonstrated that the Fc receptor capacity of CSF-1-derived macrophages from C3H/HeJ mice could be markedly inhibited by exposure to anti-IFN-cxL/ antibody either before or after removal of the CSF-1 stimulus.
The precise relationship of the endogenous IFN defect and LPS hyporesponsiveness remains elusive at this time. If one assumes that the primary Lpsddefect results in the failure of C3H/HeJ macrophages to respond to LPS due to a membrane defect, which is consistent with the findings of several investigators (6, 13), then the failure of the macrophage to be triggered by LPS to produce endogenous differentiative signals, such as CSF or IFN, Would be compromised. Alternatively, or perhaps as a result of this primary lesion, the failure to produce endogenous cytokines may result in macrophages which are hyporesponsive to LPS due to a secondary defect, i.e., a decreased state of macrophage differentiation. This latter hypothesis is consistent with a number of observations. Specifically, potent macrophageactivating agents increase LPS sensitivity in vivo (3, 28) , even in the C3H/HeJ strain (34) . Treatment of C3H/HeJ peritoneal macrophages in vitro with lymphokine-rich culture supernatants increases their capacity to release interleukin 1 in response to LPS stimulation (33) , and CSF-iderived macrophages from both Lps' and Lpsd mice were found to exhibit increased sensitivity to LPS (23 
